Marble Harbor Investment Counsel’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,550
Closed -$214K 209
2024
Q3
$214K Buy
+2,550
New +$201K 0.02% 201
2022
Q4
Sell
-5,600
Closed -$217K 186
2022
Q3
$217K Hold
5,600
0.03% 160
2022
Q2
$209K Hold
5,600
0.03% 176
2022
Q1
$248K Hold
5,600
0.03% 177
2021
Q4
$238K Buy
+5,600
New +$235K 0.03% 184
2021
Q3
Sell
-6,800
Closed -$291K 190
2021
Q2
$291K Sell
6,800
-600
-8% -$25.2K 0.04% 163
2021
Q1
$286K Hold
7,400
0.04% 161
2020
Q4
$266K Hold
7,400
0.04% 155
2020
Q3
$283K Hold
7,400
0.05% 137
2020
Q2
$260K Hold
7,400
0.05% 139
2020
Q1
$241K Buy
7,400
+1,000
+16% +$39.1K 0.05% 133
2019
Q4
$289K Buy
+6,400
New +$268K 0.05% 137

Other funds holding BSX

Marble Harbor Investment Counsel's BSX Position: Q4 2024 in Review

Marble Harbor Investment Counsel sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 2,550 shares — an estimated $214K sold.

Marble Harbor Investment Counsel first reported a position in BSX in Q4 2019 and held it in 12 quarters. The position peaked at $291K in Q2 2021. 1,512 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

  • Marble Harbor Investment Counsel reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
  • Marble Harbor Investment Counsel sold 2,550 Boston Scientific shares in Q4 2024, an estimated $214K.
  • Marble Harbor Investment Counsel first reported a position in Boston Scientific in Q4 2019 and held it in 12 quarters.
  • Marble Harbor Investment Counsel's Boston Scientific position peaked at $291K in Q2 2021.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Marble Harbor Investment Counsel's 13F filing for Q4 2024, filed 7 Feb 2025.